美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
45963-480-03	45963-480	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride	alosetron hydrochloride	TABLET	ORAL	20150526	20260430	NDA AUTHORIZED GENERIC	NDA021107	Actavis Pharma, Inc.	ALOSETRON HYDROCHLORIDE	1 mg/1	1 BOTTLE in 1 CARTON (45963-480-03) / 30 TABLET in 1 BOTTLE
54766-894-03	54766-894	HUMAN PRESCRIPTION DRUG	LOTRONEX	alosetron hydrochloride	TABLET	ORAL	20160711	20260430	NDA	NDA021107	Sebela Pharmaceuticals Inc.	ALOSETRON HYDROCHLORIDE	.5 mg/1	30 TABLET in 1 BOTTLE (54766-894-03)
45963-479-03	45963-479	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride	alosetron hydrochloride	TABLET	ORAL	20150526	20260430	NDA AUTHORIZED GENERIC	NDA021107	Actavis Pharma, Inc.	ALOSETRON HYDROCHLORIDE	.5 mg/1	1 BOTTLE in 1 CARTON (45963-479-03) / 30 TABLET in 1 BOTTLE
83107-013-30	83107-013	HUMAN PRESCRIPTION DRUG	LOTRONEX	alosetron hydrochloride	TABLET	ORAL	20260101	N/A	NDA	NDA021107	Legacy Pharma USA Inc.	ALOSETRON HYDROCHLORIDE	.5 mg/1	30 TABLET in 1 BOTTLE (83107-013-30)
54766-895-03	54766-895	HUMAN PRESCRIPTION DRUG	LOTRONEX	alosetron hydrochloride	TABLET	ORAL	20160711	20260430	NDA	NDA021107	Sebela Pharmaceuticals Inc.	ALOSETRON HYDROCHLORIDE	1 mg/1	30 TABLET in 1 BOTTLE (54766-895-03)
83107-012-30	83107-012	HUMAN PRESCRIPTION DRUG	LOTRONEX	alosetron hydrochloride	TABLET	ORAL	20260101	N/A	NDA	NDA021107	Legacy Pharma USA Inc.	ALOSETRON HYDROCHLORIDE	1 mg/1	30 TABLET in 1 BOTTLE (83107-012-30)